Intrexon Corp., 10% Owner at ZIOPHARM ONCOLOGY INC (ZIOP), bought 846,522 shares at $5.13 ($4.0M) on 2011-08-09, disclosed to the SEC on 2011-08-09.
Open-market purchase of $4.0M ZIOP by 10% Owner. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history).
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $4.65 | 116,112 | $540K | 13.4% |
| 2 | $4.58 | 444,892 | $2.0M | 50.4% |
| 3 | $5.13 | 285,518 | $1.5M | 36.2% |
| Total | $4.78 avg | 846,522 | $4.0M | 100% |
| Filing → |
| AQB | BUY | 2018-01-19 | $10.0M | — | Filing → |
| FCSC | BUY | 2017-12-13 | $4.2M | — | Filing → |
| AQB | BUY | 2017-01-20 | $25.0M | — | Filing → |